General Range
AMOXYNORM 625 LB
Price on request/100 · MOQ 100 boxes
Amoxynorm 625 LB Tablets by Enormmed Pharma Private Limited contain Amoxycillin, Potassium Clavulanate and Lactic Acid Bacillus, a combination formulated for the treatment of certain bacterial infections with additional probiotic support.
Amoxycillin is a penicillin-class antibiotic that works by inhibiting bacterial cell wall synthesis, helping eliminate susceptible bacteria. Potassium Clavulanate is a beta-lactamase inhibitor that protects Amoxycillin from breakdown by certain bacterial enzymes, extending its antibacterial activity.
Lactic Acid Bacillus is a probiotic ingredient included to support intestinal microbial balance during antibiotic treatment. Its effectiveness in reducing antibiotic-associated digestive disturbances depends on the specific probiotic strain and formulation.
Amoxynorm 625 LB Tablets may be prescribed for selected respiratory tract, throat, sinus, ear, urinary tract, skin and dental bacterial infections when clinically appropriate.
The medicine should be taken strictly according to a registered medical practitioner's prescription. Dosage and treatment duration depend on the infection, bacterial susceptibility and the patient's medical condition.
CategoryGeneral Range
Min. Order100 boxes
Supplied byEnorm Med Pharma Pvt. Ltd.
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Amoxycillin, Potassium Clavulanate & Lactic Acid Bacillus Tablets
- Packaging Type
- Tablets
- Packaging Size
- 10 × 10
- Dosage Form
- Tablet
- Treatment
- May help reduce antibiotic-associated digestive disturbances, depending on the probiotic strain and formulation.
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Enorm Med Pharma Pvt. Ltd.Panchkula, Haryana
Enorm Med Pharma Private Limited is an Indian pharmaceutical company based in Panchkula, Haryana, specializing in the manufacture, trade, wholesale, and export of a wide range of pharmaceutical formulations.
Company Overview
• Incorporation / Establishment: Originally started as a proprietorship in 2021, later incorporated as a private limited company on April 9, 2023 (CIN: U46497HR2023PTC110540).
• Registered Address: SCO 272, Sector-20, Panchkula, Haryana – 134116, India.
• Directors / Leadership: Sukhinder Jindal and Gurpreet Jindal.
• Certifications: ISO 9001:2015 and WHO-GMP compliant operations/standards.
• Business Model: PCD (Propaganda Cum Distribution) Pharma Franchise, third-party manufacturing, wholesale distribution, and domestic/global supply.
Product Portfolio
Enorm Med Pharma deals in diverse therapeutic segments and dosage forms, including:
• Dosage Forms: Tablets, capsules, softgelatin capsules, syrups, dry syrups, injections (vials), and ointments.
• Therapeutic Ranges: Anti-infectives, cardiac, diabetic, dermatology, and general wellness/herbal formulas.
• Notable Branded Products: Azeenorm (Azithromycin), Diclonorm, Enomzole-D, Levonorm, Pantenorm, Norsunate (Artesunate injections), and Mebenorm.
More General Range
